Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
15 Jul 2021 |
RESOLUTIONS |
Resolutions
-
RES10 ‐
Resolution of allotment of securities
-
RES11 ‐
Resolution of removal of pre-emption rights
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
15 Jul 2021 |
MA |
Memorandum and Articles of Association
|
|
|
29 Jun 2021 |
SH01 |
Statement of capital following an allotment of shares on 17 June 2021
|
|
|
29 Jan 2021 |
SH01 |
Statement of capital following an allotment of shares on 27 January 2021
|
|
|
11 Nov 2020 |
AD01 |
Registered office address changed from Translation & Innovation Hub 80 Wood Lane London W12 0BZ United Kingdom to Translation & Innovation Hub 84 Wood Lane London W12 0BZ on 11 November 2020
|
|
|
11 Nov 2020 |
CS01 |
Confirmation statement made on 3 November 2020 with updates
|
|
|
10 Nov 2020 |
SH01 |
Statement of capital following an allotment of shares on 29 October 2020
|
|
|
18 Sep 2020 |
SH01 |
Statement of capital following an allotment of shares on 7 September 2020
|
|
|
24 Aug 2020 |
PSC08 |
Notification of a person with significant control statement
|
|
|
21 Aug 2020 |
PSC07 |
Cessation of Heptares Therapeutics Limited as a person with significant control on 4 August 2020
|
|
|
21 Aug 2020 |
MA |
Memorandum and Articles of Association
|
|
|
21 Aug 2020 |
RESOLUTIONS |
Resolutions
-
RES11 ‐
Resolution of removal of pre-emption rights
-
RES10 ‐
Resolution of allotment of securities
|
|
|
10 Aug 2020 |
SH01 |
Statement of capital following an allotment of shares on 4 August 2020
|
|
|
10 Aug 2020 |
AP01 |
Appointment of Dr. Gur-Arye Roshwalb as a director on 4 August 2020
|
|
|
09 Mar 2020 |
AA |
Total exemption full accounts made up to 31 December 2019
|
|
|
08 Nov 2019 |
RP04SH01 |
Second filing of a statement of capital following an allotment of shares on 11 September 2019
|
|
|
06 Nov 2019 |
CS01 |
Confirmation statement made on 3 November 2019 with updates
|
|
|
01 Nov 2019 |
SH01 |
Statement of capital following an allotment of shares on 11 September 2019
|
|
|
09 Oct 2019 |
SH01 |
Statement of capital following an allotment of shares on 11 September 2019
-
ANNOTATION
Clarification a second filed SH01 was registered on 08/11/2019.
|
|
|
11 Jul 2019 |
PSC02 |
Notification of Heptares Therapeutics Limited as a person with significant control on 29 November 2018
|
|
|
11 Jul 2019 |
PSC07 |
Cessation of Sosei R&D Limited as a person with significant control on 29 November 2018
|
|
|
11 Jul 2019 |
PSC02 |
Notification of Sosei R&D Limited as a person with significant control on 2 May 2017
|
|
|
11 Jul 2019 |
PSC09 |
Withdrawal of a person with significant control statement on 11 July 2019
|
|
|
25 Jun 2019 |
AA |
Accounts for a small company made up to 31 December 2018
|
|
|
19 Jun 2019 |
RESOLUTIONS |
Resolutions
-
RES10 ‐
Resolution of allotment of securities
|
|